Posts Tagged ‘US FDA’
Anti obesity drug Sibutramine withdrawn from US markets due to adverse cardiovascular risk
Posted by: admin on: July 22, 2011
Abbott Laboratories has withdrawn the obesity drug Sibutramine (Meridia) from the market in light of clinical trial data pointing to an increased risk for stroke and myocardial infarction, the US Food and Drug Administration (FDA) announced. The agency asked Abbott Laboratories to pull the drug from the market after it evaluated data from a […]
Are You Prescribing Unapproved Drugs?
Posted by: admin on: July 11, 2011
Dr. Charles Lee. Medical officer in the Office of Compliance at the US Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research. Many healthcare providers are unaware that unapproved drugs exist and that they can pose a significant public health risk. Many of these products have been on the market for a significant […]
Search
- drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
- rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
- nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards
